Literature DB >> 2973796

A five- to seven-year experience with externally-supported Dacron prostheses in axillofemoral and femoropopliteal bypass.

G A Schultz1, L R Sauvage, S R Mathisen, P B Mansfield, J C Smith, C C Davis, D G Hall, E A Rittenhouse, T E Kowalsky.   

Abstract

We have examined the clinical results of 56 externally-supported (EXS) Dacron grafts in the axillofemoral position and 117 in the femoropopliteal position. Results have been analyzed from two perspectives: primary patency concerns only those grafts that had never occluded; extended patency refers to all open grafts including those whose continued patency is the result of thrombectomy. The 5-to 7-year life-table patency rates are: axillofemoral 8 mm and 6 mm bypass: primary 75% and extended 97%; above-knee femoropopliteal 6 mm bypass: primary 78% and extended 93%; below-knee 6 mm femoropopliteal bypass: primary 41% and extended 91%. In contrast, the results for the 5 mm grafts used for femoropopliteal bypass were inferior to the 6 mm grafts: femoropopliteal 5 mm bypasses had an above-knee primary patency rate of 44% and an extended rate of 55%, with a below-knee primary patency rate of 15% and an extended rate of 32%. Rendering the noncrimped porous Dacron prosthesis kink and compression resistant by an external support coil appears to increase its potential for successful use, especially in 8 mm axillofemoral and 6 mm femoropopliteal bypasses.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2973796     DOI: 10.1016/S0890-5096(06)61982-1

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  1 in total

1.  Benefits of arterial reconstruction in claudication.

Authors:  T Ohta; R Kato; I Sugimoto; K Hida; J Hachiya; E Mihara; T Hasegawa; Y Imamura; H Ishibashi; M Hosaka
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.